Morgan Stanley’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Morgan Stanley’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,287	Closed	-$759K	–	6868
2018 Q1	$759K	Buy	+20,287	New	+$853K	﹤0.01%	4740

Morgan Stanley's ARMO Position: Q2 2018 in Review

Morgan Stanley sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 20,287 shares — an estimated $759K sold.

Morgan Stanley first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $759K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Morgan Stanley reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Morgan Stanley sold 20,287 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $759K.
Morgan Stanley first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Morgan Stanley's ARMO BioSciences, Inc. Common Stock position peaked at $759K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Morgan Stanley's 13F filing for Q2 2018, filed 14 Aug 2018.